GXMC
ICPT

Global X Management Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Global X Management Company’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-300
Closed -$18K – 1201
2018
Q1 		$18K Buy
300
+14
+5% +$844 ﹤0.01% 1120
2017
Q4 		$17K Buy
286
+72
+34% +$4.54K ﹤0.01% 1033
2017
Q3 		$12K Buy
214
+7
+3% +$754 ﹤0.01% 1097
2017
Q2 		$25K Buy
207
+57
+38% +$6.6K ﹤0.01% 1103
2017
Q1 		$17K Buy
+150
New +$17.5K ﹤0.01% 1105

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Global X Management Company's ICPT Position: Q2 2018 in Review

Global X Management Company sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2018, closing a stake of 300 shares — an estimated $18K sold.

Global X Management Company first reported a position in ICPT in Q1 2017 and held it in 5 quarters. The position peaked at $25K in Q2 2017. 163 funds tracked by Wall St. Rank hold ICPT as of Q2 2018.

  • Global X Management Company reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Global X Management Company sold 300 Intercept Pharmaceuticals, Inc. shares in Q2 2018, an estimated $18K.
  • Global X Management Company first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 5 quarters.
  • Global X Management Company's Intercept Pharmaceuticals, Inc. position peaked at $25K in Q2 2017.
  • 163 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.